Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Eqvalan Patent Expiration

Eqvalan Petitions

Details of Eqvalan's suitability petitions are listed below.

Petitioner Action Date of Action Description
Petitions Data
First Priority, Inc. Filed 16 Jan, 2004 The generic product will have a different dosage form and strength from the pioneer.
Eugene G. Keller Approved 04 Dec, 2003 The generic product will have a different strength and dosage form from the pioneer.
Richdel, Inc. Approved 31 Jul, 2003 The generic product will have a different dosage form from the pioneer.
Karen A. Sisson Approved 17 Apr, 2003 The generic product will consist of a different dosage form from the pioneer.
First Priority, Inc. Filed 05 Mar, 2003 The generic product will have a different dosage form and strength from the pioneer.
Highland VetPharma, LLC Approved 10 Dec, 2002 The generic product will consist of a different dosage form and strength from the pioneer.
Intervet, Inc. Approved 10 Dec, 2002 The generic product will consist of a different dosage form and strength from the pioneer.
Richdel, Inc. Approved 07 Nov, 2002 The generic product will consist of a different dosage form from the pioneer.
Karen A. Sisson Approved 21 Oct, 2002 The generic product will consist of a different dosage form from the pioneer.
Equi Aid Products, Inc. Approved 18 Sep, 2002 The generic product will consist of a different dosage form and strength from the pioneer.
Highland VetPharma, LLC Denied 26 Jul, 2001 The generic product will consist of a different dosage form from the pioneer.
Buford Biomedical, Inc. Denied 26 Jul, 2001 Ivermectin generic is a 6.8% powder formulation to be administered in the feed.
Equi Aid Products, Inc. Denied 26 Jul, 2001 The generic product will consist of a different dosage form and strength from the pioneer.
Equi Aid Products, Inc. Denied 30 Jun, 2000 The generic product will consist of a different dosage form , different route of administration , and different strength from the pioneer.

About Eqvalan

Eqvalan is a drug owned by BOEHRINGER LNGELHEIM ANIMAL HEALTH USA, INC. Eqvalan uses Ivermectin as the active ingredient.

Active Ingredient:

Eqvalan uses Ivermectin as the active ingredient. Check out other Drugs and Companies using Ivermectin ingredient.